Citations (91)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (24)
Inês Alves, Marta Gromicho, Miguel Oliveira Santos, Susana Pinto, Ana Pronto-Laborinho, Michael Swash & Mamede de Carvalho. (2023) Demographic changes in a large motor neuron disease cohort in Portugal: a 27 year experience. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:7-8, pages 614-624.
Read now
Read now
Elisa Bianchi, Elisabetta Pupillo, Antonio De Feudis, Gabriele Enia, Eugenio Vitelli & Ettore Beghi. (2022) Trends in survival of ALS from a population-based registry. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 23:5-6, pages 344-352.
Read now
Read now
Richard Bedlack, Sky Kihuwa-mani, Paul E. Barkhaus, Michael Bereman, James B. Caress, Jesse Crayle, Gary L. Pattee, Terry Heiman Patterson, Paul Wicks, Neta Zach, Gregory T. Carter & Kristiana Salmon. (2021) ALSUntangled 59: Tamoxifen. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22:7-8, pages 595-598.
Read now
Read now
Fakhra Amin, Mohd Shahnawaz Khan & Bilqees Bano. (2020) Mammalian cystatin and protagonists in brain diseases. Journal of Biomolecular Structure and Dynamics 38:7, pages 2171-2196.
Read now
Read now
Suma Babu, Eric A. Macklin, Katherine E. Jackson, Elizabeth Simpson, Katy Mahoney, Hong Yu, Jason Walker, Zachary Simmons, William S. David, Paul E. Barkhaus, Laura Simionescu, Mazen M. Dimachkie, Alan Pestronk, Johnny S. Salameh, Michael D. Weiss, Benjamin Rix Brooks, David Schoenfeld, Jeremy Shefner, Swati Aggarwal, Merit E. Cudkowicz & Nazem Atassi. (2020) Selection design phase II trial of high dosages of tamoxifen and creatine in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21:1-2, pages 15-23.
Read now
Read now
Alon Abraham, Beatrice Nefussy, Yaara Fainmesser, Yoram Ebrahimi, Arnon Karni & Vivian E. Drory. (2019) Early post-marketing experience with edaravone in an unselected group of patients with ALS. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20:3-4, pages 260-263.
Read now
Read now
Nilda Turgut, Gamze Varol SaraÇoglu, Selahattin Kat, Kemal Balci, BabÜrhan GÜldiken, Ozlem Birgili & Levent Kabayel. (2019) An epidemiologic investigation of amyotrophic lateral sclerosis in Thrace, Turkey, 2006–2010*. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20:1-2, pages 100-106.
Read now
Read now
Susana Pinto & Mamede De Carvalho. (2017) Seasons and ALS time of death. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 18:3-4, pages 291-295.
Read now
Read now
Marina Tesauro, Michela Consonni, Tommaso Filippini, Letizia Mazzini, Fabrizio Pisano, Adriano Chiò, Aniello Esposito & Marco Vinceti. (2017) Incidence of amyotrophic lateral sclerosis in the province of Novara, Italy, and possible role of environmental pollution. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 18:3-4, pages 284-290.
Read now
Read now
H Blasco, F Patin, CR Andres, P Corcia & PH Gordon. (2016) Amyotrophic Lateral Sclerosis, 2016: existing therapies and the ongoing search for neuroprotection. Expert Opinion on Pharmacotherapy 17:12, pages 1669-1682.
Read now
Read now
Caroline Ingre, Per M Roos, Fredrik Piehl, Freya Kamel & Fang Fang. (2015) Risk factors for amyotrophic lateral sclerosis. Clinical Epidemiology 7, pages 181-193.
Read now
Read now
Hosein Shamshiri, Farzad Fatehi, Farnoush Davoudi, Elham Mir, Behin Pourmirza, Roya Abolfazli, Masoud Etemadifar, Mohammad Hossein Harirchian, Koroush Gharagozli, Hormoz Ayromlou, Keivan Basiri, Babak Zamani, Mohammad Rohani, Behnaz Sedighi, Ali Roudbari, Hossein Delavar Kasmaei, Karim Nikkhah, Alireza Ranjbar Naeini & Shahriar Nafissi. (2015) Amyotrophic lateral sclerosis progression: Iran-ALS clinical registry, a multicentre study. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 16:7-8, pages 506-511.
Read now
Read now
Lisa A. van der Kleij, Ashley R. Jones, I Nick Steen, Carolyn A. Young, Pamela J. Shaw, Christopher E. Shaw, P. Nigel Leigh, Martin R. Turner & Ammar Al-Chalabi. (2015) Regionality of disease progression predicts prognosis in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 16:7-8, pages 442-447.
Read now
Read now
Hazuki Watanabe, Naoki Atsuta, Ryoichi Nakamura, Akihiro Hirakawa, Hirohisa Watanabe, Mizuki Ito, Jo Senda, Masahisa Katsuno, Yuishin Izumi, Mitsuya Morita, Hiroyuki Tomiyama, Akira Taniguchi, Ikuko Aiba, Koji Abe, Kouichi Mizoguchi, Masaya Oda, Osamu Kano, Koichi Okamoto, Satoshi Kuwabara, Kazuko Hasegawa, Takashi Imai, Masashi Aoki, Shoji Tsuji, Imaharu Nakano, Ryuji Kaji & Gen Sobue. (2015) Factors affecting longitudinal functional decline and survival in amyotrophic lateral sclerosis patients. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 16:3-4, pages 230-236.
Read now
Read now
Noa Keren, Kirsten M. Scott, Miho Tsuda, Jessica Barnwell, Jonathan A. Knibb, Cathy M. Ellis, P. Nigel Leigh, Christopher E. Shaw & Ammar Al-Chalabi. (2014) Evidence of an environmental effect on survival in ALS. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 15:7-8, pages 528-533.
Read now
Read now
Christopher B. Brady, Katrina T. Trevor, Thor D. Stein, Eva Y. Deykin, Sally D. Perkins, James G. Averill, Latease Guilderson, Ann C. Mckee, Stephen W. Renner & Neil W. Kowall. (2013) The Department of Veterans Affairs Biorepository Brain Bank: A national resource for amyotrophic lateral sclerosis research. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 14:7-8, pages 591-597.
Read now
Read now
Bart Vrijsen, Dries Testelmans, Catharina Belge, Wim Robberecht, Philip Van Damme & Bertien Buyse. (2013) Non-invasive ventilation in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 14:2, pages 85-95.
Read now
Read now
Jens Kuhle & Axel Petzold. (2011) What makes a prognostic biomarker in CNS diseases: strategies for targeted biomarker discovery? Part 2: chronic progressive and relapsing disease. Expert Opinion on Medical Diagnostics 5:5, pages 393-410.
Read now
Read now
Muddasir Qureshi, David A. Schoenfeld, Yuvika Paliwal, Amy Shui & Merit E. Cudkowicz. (2009) The natural history of ALS is changing: Improved survival. Amyotrophic Lateral Sclerosis 10:5-6, pages 324-331.
Read now
Read now
Adriano Chiò, Giancarlo Logroscino, Orla Hardiman, Robert Swingler, Douglas Mitchell, Ettore Beghi, Bryan G. Traynor & On Behalf of the Eurals Consortium. (2009) Prognostic factors in ALS: A critical review. Amyotrophic Lateral Sclerosis 10:5-6, pages 310-323.
Read now
Read now
Daniel M. Pastula, Cynthia J. Coffman, Kelli D. Allen, Eugene Z. Oddone, Edward J. Kasarskis, Jennifer H. Lindquist, Joel C. Morgenlander, Barbara B. Norman, Marvin P. Rozear, Laura A. Sams, Arman Sabet & Richard S. Bedlack. (2009) Factors associated with survival in the National Registry of Veterans with ALS. Amyotrophic Lateral Sclerosis 10:5-6, pages 332-338.
Read now
Read now
Jaydeep M Bhatt & Paul H Gordon. (2007) Current clinical trials in amyotrophic lateral sclerosis. Expert Opinion on Investigational Drugs 16:8, pages 1197-1207.
Read now
Read now
Robert Bowser, Merit Cudkowicz & Rima Kaddurah-Daouk. (2006) Biomarkers for amyotrophic lateral sclerosis. Expert Review of Molecular Diagnostics 6:3, pages 387-398.
Read now
Read now
REUVEN SANDYK. (2006) SEROTONERGIC MECHANISMS IN AMYOTROPHIC LATERAL SCLEROSIS. International Journal of Neuroscience 116:7, pages 775-826.
Read now
Read now
Articles from other publishers (67)
Eva Bagyinszky, John Hulme & Seong Soo A. An. (2023) Studies of Genetic and Proteomic Risk Factors of Amyotrophic Lateral Sclerosis Inspire Biomarker Development and Gene Therapy. Cells 12:15, pages 1948.
Crossref
Crossref
Evan Udine, Angita Jain & Marka van Blitterswijk. (2023) Advances in sequencing technologies for amyotrophic lateral sclerosis research. Molecular Neurodegeneration 18:1.
Crossref
Crossref
Jan Sznajder, Krzysztof Barć & Magdalena Kuźma-Kozakiewicz. (2022) Physical activity in patients with amyotrophic lateral sclerosis: Prevalence, patients’ perspectives and relation to the motor performance. NeuroRehabilitation 50:4, pages 433-443.
Crossref
Crossref
Vidhi Bhatt, Connor Kydd & Mehak Behal. (2022) Risk Factors of Amyotrophic Lateral Sclerosis (ALS): An Updated Systematic Review. Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal 6:5, pages 1-11.
Crossref
Crossref
Cheng Li, Yu Zhu, Wenzhi Chen, Menghua Li, Mi Yang, Ziyang Shen, Yiyi Zhou, Lulu Wang, Huan Wang, Shu Li, Jiacheng Ma, Mengni Gong & Renshi Xu. (2022) Circulating NAD+ Metabolism-Derived Genes Unveils Prognostic and Peripheral Immune Infiltration in Amyotrophic Lateral Sclerosis. Frontiers in Cell and Developmental Biology 10.
Crossref
Crossref
Robert J. Nona, Zhouwei Xu, Gail A. Robinson, Robert D. Henderson & Pamela A. McCombe. (2022) Age of Onset and Length of Survival of Queensland Patients with Amyotrophic Lateral Sclerosis: Details of Subjects with Early Onset and Subjects with Long Survival. Neurodegenerative Diseases 22:3-4, pages 104-121.
Crossref
Crossref
Pei-Chien TsaiKang-Yang JihTing-Yi ShenYi-Hong LiuKon-Ping LinYi-Chu LiaoYi-Chung Lee. (2021) Genetic and Functional Analysis of Glycosyltransferase 8 Domain–Containing Protein 1 in Taiwanese Patients With Amyotrophic Lateral Sclerosis. Neurology Genetics 7:6.
Crossref
Crossref
Wei-Ming Su, Yang-Fan Cheng, Zheng Jiang, Qing-Qing Duan, Tian-Mi Yang, Hui-Fang Shang & Yong-Ping Chen. (2021) Predictors of survival in patients with amyotrophic lateral sclerosis: A large meta-analysis. eBioMedicine 74, pages 103732.
Crossref
Crossref
Alok Sharma, Hemangi Sane, Amruta Paranjape, Ritu Varghese, Vivek Nair, Hema Biju, Dhanashree Sawant, Nandini Gokulchandran & Prerna Badhe. (2021) Improved survival in amyotrophic lateral sclerosis patients following autologous bone marrow mononuclear cell therapy: a long term 10-year retrospective study. Journal of Neurorestoratology 9:2, pages 117-136.
Crossref
Crossref
Yu‐Shuen Tsai, Kon‐Ping Lin, Kang‐Yang Jih, Pei‐Chien Tsai, Yi‐Chu Liao & Yi‐Chung Lee. (2020)
Hand‐onset weakness is a common feature of ALS patients with a
NEK1
loss‐of‐function variant
. Annals of Clinical and Translational Neurology 7:6, pages 965-971.
Crossref
Crossref
Kate L. Osman, Sabrina Kohlberg, Alexis Mok, Ryan Brooks, Lori A. Lind, Katelyn McCormack, Andries Ferreira, Matan Kadosh, Mary K. Fagan, Elizabeth Bearce, Nicole L. Nichols, Joan R. Coates & Teresa E. Lever. (2019) Optimizing the Translational Value of Mouse Models of ALS for Dysphagia Therapeutic Discovery. Dysphagia 35:2, pages 343-359.
Crossref
Crossref
Kazushi Okamoto. 2019. Epidemiological Studies of Specified Rare and Intractable Disease. Epidemiological Studies of Specified Rare and Intractable Disease
47
59
.
Alex G. Karanevich, Luke J. Weisbrod, Omar Jawdat, Richard J. Barohn, Byron J. Gajewski, Jianghua He & Jeffrey M. Statland. (2018) Using automated electronic medical record data extraction to model ALS survival and progression. BMC Neurology 18:1.
Crossref
Crossref
Victoria L. Hodgkinson, Josh Lounsberry, Ario Mirian, Angela Genge, Timothy Benstead, Hannah Briemberg, Ian Grant, Walter Hader, Wendy S. Johnston, Sanjay Kalra, Gary Linassi, Rami Massie, Michel Melanson, Colleen O’Connell, Kerri Schellenberg, Christen Shoesmith, Sean Taylor, Scott Worley, Lorne Zinman & Lawrence Korngut. (2018) Provincial Differences in the Diagnosis and Care of Amyotrophic Lateral Sclerosis. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 45:6, pages 652-659.
Crossref
Crossref
Stephen R. Pfohl, Renaid B. Kim, Grant S. Coan & Cassie S. Mitchell. (2018) Unraveling the Complexity of Amyotrophic Lateral Sclerosis Survival Prediction. Frontiers in Neuroinformatics 12.
Crossref
Crossref
Pei-Chien Tsai, Yi-Chu Liao, Po-Lin Chen, Yuh-Cherng Guo, Ying-Hao Chen, Kang-Yang Jih, Kon-Ping Lin, Bing-Wen Soong, Ching-Paio Tsai & Yi-Chung Lee. (2018) Investigating CCNF mutations in a Taiwanese cohort with amyotrophic lateral sclerosis. Neurobiology of Aging 62, pages 243.e1-243.e6.
Crossref
Crossref
Yuanyuan Qin, Shun Zhang, Rifeng Jiang, Fei Gao, Xiaoying Tang & Wenzhen Zhu. (2018) Region-specific atrophy of precentral gyrus in patients with amyotrophic lateral sclerosis. Journal of Magnetic Resonance Imaging 47:1, pages 115-122.
Crossref
Crossref
Loutfi S. Aboussouan & Eduardo Mireles-Cabodevila. (2017) Sleep-Disordered Breathing in Neuromuscular Disease. Chest 152:4, pages 880-892.
Crossref
Crossref
Yang Hu, Chang Cao, Xiao-Yan Qin, Yun Yu, Jing Yuan, Yu Zhao & Yong Cheng. (2017) Increased peripheral blood inflammatory cytokine levels in amyotrophic lateral sclerosis: a meta-analysis study. Scientific Reports 7:1.
Crossref
Crossref
Ming-Dong Wang, Julian Little, James Gomes, Neil R. Cashman & Daniel Krewski. (2017) Identification of risk factors associated with onset and progression of amyotrophic lateral sclerosis using systematic review and meta-analysis. NeuroToxicology 61, pages 101-130.
Crossref
Crossref
Karin N. Wagner, Haikady Nagaraja, Dawn C. Allain, Adam Quick, Stephen Kolb & Jennifer Roggenbuck. (2016) Patients with Amyotrophic Lateral Sclerosis Have High Interest in and Limited Access to Genetic Testing. Journal of Genetic Counseling 26:3, pages 604-611.
Crossref
Crossref
M.J. Magnussen & J.D. Glass. 2017. Molecular and Cellular Therapies for Motor Neuron Diseases. Molecular and Cellular Therapies for Motor Neuron Diseases
25
41
.
Sung-Pil Yang, Jin-Young Kim, Ji-won Lee & Eui-Ju Lee. (2016) A Case Report of a Soeumin Patient with Dyspnea Induced by Neuromuscular Disease. Journal of Sasang Constitutional Medicine 28:4, pages 403-411.
Crossref
Crossref
Eva Vlčková. (2016) Amyotrophic lateral sclerosis. Neurologie pro praxi 17:6, pages 362-365.
Crossref
Crossref
Vincent Picher-Martel, Paul N. Valdmanis, Peter V. Gould, Jean-Pierre Julien & Nicolas Dupré. (2016) From animal models to human disease: a genetic approach for personalized medicine in ALS. Acta Neuropathologica Communications 4:1.
Crossref
Crossref
Annerieke C. van Groenestijn, Esther T. Kruitwagen-van Reenen, Johanna M. A. Visser-Meily, Leonard H. van den Berg & Carin D. Schröder. (2016) Associations between psychological factors and health-related quality of life and global quality of life in patients with ALS: a systematic review. Health and Quality of Life Outcomes 14:1.
Crossref
Crossref
Hosein Shamshiri, Farzad Fatehi, Roya Abolfazli, Mohammad Hossein Harirchian, Behnaz Sedighi, Babak Zamani, Ali Roudbari, Nazanin Razazian, Fatemeh Khamseh & Shahriar Nafissi. (2016) Trends of quality of life changes in amyotrophic lateral sclerosis patients. Journal of the Neurological Sciences 368, pages 35-40.
Crossref
Crossref
Siyuan Li, Yuting Ren, Wenjia Zhu, Fei Yang, Xiaolan Zhang & Xusheng Huang. (2016) Phosphorylated neurofilament heavy chain levels in paired plasma and CSF of amyotrophic lateral sclerosis. Journal of the Neurological Sciences 367, pages 269-274.
Crossref
Crossref
Kota Bokuda, Toshio Shimizu, Kazuhiro Imamura, Akihiro Kawata, Kazuhiko Watabe, Masaharu Hayashi, Yuki Nakayama, Eiji Isozaki & Imaharu Nakano. (2016) Predictive factors for prognosis following unsedated percutaneous endoscopic gastrostomy in ALS patients. Muscle & Nerve 54:2, pages 277-283.
Crossref
Crossref
Daichi Yokoi, Naoki Atsuta, Hazuki Watanabe, Ryoichi Nakamura, Akihiro Hirakawa, Mizuki Ito, Hirohisa Watanabe, Masahisa Katsuno, Yuishin Izumi, Mitsuya Morita, Akira Taniguchi, Masaya Oda, Koji Abe, Kouichi Mizoguchi, Osamu Kano, Satoshi Kuwabara, Ryuji Kaji & Gen Sobue. (2016) Age of onset differentially influences the progression of regional dysfunction in sporadic amyotrophic lateral sclerosis. Journal of Neurology 263:6, pages 1129-1136.
Crossref
Crossref
Nilo Riva, Federica Agosta, Christian Lunetta, Massimo Filippi & Angelo Quattrini. (2016) Recent advances in amyotrophic lateral sclerosis. Journal of Neurology 263:6, pages 1241-1254.
Crossref
Crossref
Pei-Chien Tsai, Yi-Chien Liu, Kon-Ping Lin, Yo-Tsen Liu, Yi-Chu Liao, Cheng-Tsung Hsiao, Bing-Wen Soong, Ping-Keung Yip & Yi-Chung Lee. (2016) Mutational analysis of TBK1 in Taiwanese patients with amyotrophic lateral sclerosis. Neurobiology of Aging 40, pages 191.e11-191.e16.
Crossref
Crossref
Blanka Adamová, Iva Šrotová & Jakub Stulík. (2016) Lumbar spinal stenosis or amyotrophic lateral sclerosis?. Neurologie pro praxi 17:2, pages 117-122.
Crossref
Crossref
Sebum Lee, Yulei Shang & Eric J. Huang. 2016. Dendrites. Dendrites
545
579
.
Scott P. Allen, Lynn M. Duffy, Pamela J. Shaw & Andrew J. Grierson. (2015) Altered age-related changes in bioenergetic properties and mitochondrial morphology in fibroblasts from sporadic amyotrophic lateral sclerosis patients. Neurobiology of Aging 36:10, pages 2893-2903.
Crossref
Crossref
Susan T. Paulukonis, Eric M. Roberts, Jhaqueline P. Valle, Natalie N. Collins, Paul B. English & Wendy E. Kaye. (2015) Survival and Cause of Death among a Cohort of Confirmed Amyotrophic Lateral Sclerosis Cases. PLOS ONE 10:7, pages e0131965.
Crossref
Crossref
Mauro Marchetti & Konstantinos Priftis. (2015) Brain–computer interfaces in amyotrophic lateral sclerosis: A metanalysis. Clinical Neurophysiology 126:6, pages 1255-1263.
Crossref
Crossref
Marwa Elamin, Peter Bede, Anna Montuschi, Niall Pender, Adriano Chio & Orla Hardiman. (2015) Predicting prognosis in amyotrophic lateral sclerosis: a simple algorithm. Journal of Neurology 262:6, pages 1447-1454.
Crossref
Crossref
Kon-Ping Lin, Pei-Chien Tsai, Yi-Chu Liao, Wei-Ting Chen, Ching-Piao Tsai, Bing-Wen Soong & Yi-Chung Lee. (2015) Mutational analysis of MATR3 in Taiwanese patients with amyotrophic lateral sclerosis. Neurobiology of Aging 36:5, pages 2005.e1-2005.e4.
Crossref
Crossref
Neta Zach, David L. Ennist, Albert A. Taylor, Hagit Alon, Alexander Sherman, Robert Kueffner, Jason Walker, Ervin Sinani, Igor Katsovskiy, Merit Cudkowicz & Melanie L. Leitner. (2015) Being PRO-ACTive: What can a Clinical Trial Database Reveal About ALS?. Neurotherapeutics 12:2, pages 417-423.
Crossref
Crossref
Andrea L. Smith, James W. Teener, Brian C. Callaghan, Jack Harrington & Wendy R. Uhlmann. (2014) Amyotrophic Lateral Sclerosis in a Patient with a Family History of Huntington Disease: Genetic Counseling Challenges. Journal of Genetic Counseling 23:5, pages 725-733.
Crossref
Crossref
Jessica K. Paulus, Issa J. Dahabreh, Ethan M. Balk, Esther E. Avendano, Joseph Lau & Stanley Ip. (2014) Opportunities and challenges in using studies without a control group in comparative effectiveness reviews. Research Synthesis Methods 5:2, pages 152-161.
Crossref
Crossref
Osamu Kano, Konosuke Iwamoto, Hirono Ito, Yuji Kawase, Derek Cridebring, Ken Ikeda & Yasuo Iwasaki. (2013) Limb-onset amyotrophic lateral sclerosis patients visiting orthopedist show a longer time-to-diagnosis since symptom onset. BMC Neurology 13:1.
Crossref
Crossref
J. Scott Roberts & Wendy R. Uhlmann. (2013) Genetic susceptibility testing for neurodegenerative diseases: Ethical and practice issues. Progress in Neurobiology 110, pages 89-101.
Crossref
Crossref
Johnathan Cooper-Knock, Thomas Jenkins & Pamela J. Shaw. (2013) Clinical and Molecular Aspects of Motor Neuron Disease. Colloquium Series on Genomic and Molecular Medicine 2:2, pages 1-60.
Crossref
Crossref
Bradley R. Foerster, Robert C. Welsh & Eva L. Feldman. (2013) 25 years of neuroimaging in amyotrophic lateral sclerosis. Nature Reviews Neurology 9:9, pages 513-524.
Crossref
Crossref
P. Clavelou, M. Blanquet, F. Peyrol, L. Ouchchane & L. Gerbaud. (2013) Rates of progression of weight and forced vital capacity as relevant measurement to adapt Amyotrophic Lateral Sclerosis management for patient Result of a French multicentre cohort survey. Journal of the Neurological Sciences 331:1-2, pages 126-131.
Crossref
Crossref
Paul H. Gordon, François Salachas, Lucette Lacomblez, Nadine Le Forestier, Pierre-François Pradat, Gaelle Bruneteau, Alexis Elbaz & Vincent Meininger. (2013) Predicting Survival of Patients with Amyotrophic Lateral Sclerosis at Presentation: A 15-Year Experience. Neurodegenerative Diseases 12:2, pages 81-90.
Crossref
Crossref
Daniel M Pastula, Dan H Moore & Richard S Bedlack. (2012) Creatine for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Ching-Paio Tsai, Bing-Wen Soong, Pang-Hsien Tu, Kon-Ping Lin, Jong-Ling Fuh, Pei-Chien Tsai, Yi-Chun Lu, I-Hui Lee & Yi-Chung Lee. (2012) A hexanucleotide repeat expansion in C9ORF72 causes familial and sporadic ALS in Taiwan. Neurobiology of Aging 33:9, pages 2232.e11-2232.e18.
Crossref
Crossref
Nazem Atassi, David Schoenfeld & Merit Cudkowicz. 2012. Clinical Trials in Neurology. Clinical Trials in Neurology
273
283
.
. 2012. Clinical Trials in Neurology. Clinical Trials in Neurology
215
308
.
M. ElaminJ. PhukanP. BedeN. JordanS. ByrneN. PenderO. Hardiman. (2011) Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia. Neurology 76:14, pages 1263-1269.
Crossref
Crossref
Ryan Vass, Emily Ashbridge, Felix Geser, William T. Hu, Murray Grossman, Dana Clay-Falcone, Lauren Elman, Leo McCluskey, Virginia M. Y. Lee, Vivianna M. Van Deerlin, John Q. Trojanowski & Alice S. Chen-Plotkin. (2010) Risk genotypes at TMEM106B are associated with cognitive impairment in amyotrophic lateral sclerosis. Acta Neuropathologica 121:3, pages 373-380.
Crossref
Crossref
Meghan E. Wilson, Imene Boumaza, David Lacomis & Robert Bowser. (2010) Cystatin C: A Candidate Biomarker for Amyotrophic Lateral Sclerosis. PLoS ONE 5:12, pages e15133.
Crossref
Crossref
Federica Agosta, Elisabetta Pagani, Melissa Petrolini, Maria P. Sormani, Domenico Caputo, Michele Perini, Alessandro Prelle, Fabrizio Salvi & Massimo Filippi. (2010) MRI predictors of long‐term evolution in amyotrophic lateral sclerosis. European Journal of Neuroscience 32:9, pages 1490-1496.
Crossref
Crossref
Daniel M. Pastula, Dan H Moore & Richard S Bedlack. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
. (2010) What's in the Literature?. Journal of Clinical Neuromuscular Disease 11:3, pages 158-163.
Crossref
Crossref
J. Jefferson P. Perry, David S. Shin & John A. Tainer. 2010. Diseases of DNA Repair. Diseases of DNA Repair
9
20
.
Lokesh C Wijesekera & P Nigel Leigh. (2009) Amyotrophic lateral sclerosis. Orphanet Journal of Rare Diseases 4:1.
Crossref
Crossref
L. C. WijesekeraS. MathersP. TalmanC. GaltreyM. H. ParkinsonJ. GanesalingamE. WilleyM. A. AmpongC. M. EllisC. E. ShawA. Al-ChalabiP. N. Leigh. (2009) Natural history and clinical features of the flail arm and flail leg ALS variants. Neurology 72:12, pages 1087-1094.
Crossref
Crossref
Swati Aggarwal & Merit Cudkowicz. (2008) ALS drug development: Reflections from the past and a way forward. Neurotherapeutics 5:4, pages 516-527.
Crossref
Crossref
Tameko Kihira, Sohei Yoshida, Kazusi Okamoto, Yoshinori Kazimoto, Masae Ookawa, Kiwa Hama, Hideto Miwa & Tomoyoshi Kondo. (2008) Survival rate of patients with amyotrophic lateral sclerosis in Wakayama Prefecture, Japan, 1966 to 2005. Journal of the Neurological Sciences 268:1-2, pages 95-101.
Crossref
Crossref
Eric J. SorensonJayawant MandrekarBrian CrumJ. Clarke Stevens. (2007) Effect of referral bias on assessing survival in ALS. Neurology 68:8, pages 600-602.
Crossref
Crossref
P.-F. Pradat & G. Bruneteau. (2006) Quels sont les critères cliniques de la sclérose latérale amyotrophique en fonction des formes cliniques ?. Revue Neurologique 162, pages 29-33.
Crossref
Crossref
F. Torny, M. Lacoste, J.M. Nguyen, M.E. Tymoczko-Nguyen & P. Couratier. (2006) Étude des causes du retard au diagnostic de la sclérose latérale amyotrophique. Revue Neurologique 162:5, pages 617-622.
Crossref
Crossref
Carmelo Sidoti & Umberto Agrillo. (2006) Chronic Cortical Stimulation for Amyotropic Lateral Sclerosis: A Report of Four Consecutive Operated Cases after a 2-Year Follow-up: Technical Case Report. Neurosurgery 58:2, pages E384.
Crossref
Crossref